Bausch + Lomb (BLCO) ZACKS·2025-02-19 14:05Core Viewpoint - Bausch + Lomb reported quarterly earnings of $0.25 per share, exceeding the Zacks Consensus Estimate of $0.24 per share, and showing a year-over-year increase from $0.24 per share [1] Group 1: Earnings Performance - The company achieved an earnings surprise of 4.17% for the recent quarter, following a previous surprise of 6.25% [1][2] - Over the last four quarters, Bausch + Lomb has surpassed consensus EPS estimates two times [2] - The current consensus EPS estimate for the upcoming quarter is $0.16, with projected revenues of $1.17 billion [7] Group 2: Revenue Insights - Bausch + Lomb reported revenues of $1.28 billion for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 1.17% and increasing from $1.17 billion year-over-year [2] - The company has exceeded consensus revenue estimates four times over the last four quarters [2] Group 3: Stock Performance and Outlook - Bausch + Lomb shares have declined approximately 9.1% since the beginning of the year, contrasting with a 4% gain in the S&P 500 [3] - The current estimate revisions trend for Bausch + Lomb is unfavorable, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] Group 4: Industry Context - The Medical Services industry, to which Bausch + Lomb belongs, is currently ranked in the bottom 47% of over 250 Zacks industries, suggesting potential challenges ahead [8]